NEWS
RONGYAO BIOTECH
Join Us for a Grand Event | Zhejiang Rongyao Biotechnology Invites You to the CPHI 2024, the 22nd China International Pharmaceutical Ingredients Exhibition
Release time: 2024/06/19
From June 19 to 21, 2024, the 22nd CPhI China 2024—the World Pharmaceutical Ingredients Exhibition—grandly opened at the Shanghai New International Expo Center. This year’s event brought together renowned domestic and international pharmaceutical companies, research institutions, and leading experts and scholars, presenting a landmark showcase of the pharmaceutical industry for the modern era.
Zhejiang Rongyao Biotechnology is showcasing a wide array of competitive products at this exhibition, including pharmaceutical and veterinary API ingredients and intermediates. We cordially invite you to visit our booth for a tour and discussion, where we can jointly explore the development and future of the global pharmaceutical industry, help pharmaceutical companies identify new opportunities, achieve breakthroughs, and drive further growth. Since its inaugural edition in 2012, the World Pharmaceutical Ingredients China Expo has established itself as one of Asia’s leading specialized exhibitions focused on product offerings, services, and technology sharing in the fields of pharmaceutical raw materials, intermediates, formulations, and innovative drugs. The event aims to provide industry professionals with a global platform for cutting-edge product solutions, expert knowledge exchange, technological collaboration, and the commercialization of innovative solutions.
About Glory Bio
Zhejiang Honor Biotechnology Co., Ltd. is an innovative pharmaceutical enterprise integrating R&D, manufacturing, and sales, with business spanning pharmaceutical APIs and intermediates, veterinary APIs and intermediates, and CDMO services. The company has established a standardized and robust production and quality management system, having successfully obtained U.S. FDA certification six consecutive times and Ministry of Agriculture GMP certification four consecutive times, with its products exported to overseas markets.
The company places great emphasis on technological innovation and has established national-level postdoctoral workstations, provincial enterprise research institutes, and other platforms for scientific research and talent development. It has recruited high-caliber professionals, including national-level overseas talents, provincial-level overseas talents, recipients of the Provincial 151 Talent Program, Taizhou City’s Top-Tier Talents, and Taizhou City’s “500 Elite” program, to form a cutting-edge R&D and management team. In addition, the company has forged long-term industry–university–research collaboration partnerships with renowned domestic universities and research institutes such as the Chinese Academy of Sciences and Zhejiang University. Past exhibition highlights
Honor Bio steadfastly upholds its corporate mission: “Honor—Creating a Healthier Future.” We remain committed to the pharmaceutical industry’s highest standards and rigorous requirements, accelerate innovation in science and technology, and strive to become a globally integrated, innovation-driven pharmaceutical technology company. We are unwavering in our dedication to the research, development, and manufacturing of high-quality pharmaceutical products, relentlessly working to build a healthier future!